Shenzhen - Delayed Quote CNY

Anhui Gujing Distillery Co., Ltd. (000596.SZ)

164.39

-1.41

(-0.85%)

At close: April 30 at 3:04:06 PM GMT+8

Stock market today: Dow, S&P 500, Nasdaq futures slide as tariff fears revive to kick off big Fed week

A cool-down might be on the horizon as major index futures slip following a record-breaking run of gains for the S&P 500.

Yahoo Finance 3 minutes ago

NQ=F

ES=F

YM=F
Warren Buffett is stepping aside at Berkshire Hathaway. Here's what he thinks happens next.

Warren Buffett outlined years ago what it would take to be the next CEO at Berkshire Hathaway.

Yahoo Finance 21 minutes ago

BRK-B
Berkshire Hathaway (BRK.B) Sits on $300B Cash Pile, Plays the Long Game in Japan

Buffett says no to rushed deals, yes to patience and partnerships

GuruFocus.com 15 minutes ago

BRK-B
Berkshire Hathaway (BRK.A) Surges as Buffett Prepares Exit After 60 Years

Greg Abel to succeed Buffett amid record cash pile and market outperformance

GuruFocus.com 31 minutes ago

BRK-B
ON Semiconductor Corp.: Q1 Earnings Snapshot

SCOTTSDALE, Ariz. AP) — ON Semiconductor Corp. ON) on Monday reported a loss of $486.1 million in its first quarter.

Associated Press Finance 36 minutes ago

ON
onsemi Reports First Quarter 2025 Results

SCOTTSDALE, Ariz., May 05, 2025--onsemi (the "Company") (Nasdaq: ON) today announced its first quarter 2025 results with the following highlights:

Business Wire 45 minutes ago

ON
Ackman’s Pershing Square to Boost Stake in Howard Hughes Holdings

Howard Hughes Holdings said Bill Ackman’s Pershing Square Capital Management will invest $900 million in the company, boosting its stake further and bringing Ackman back into the fold.

The Wall Street Journal 49 minutes ago

HHH
Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)

The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) in all presentations matching the reference product, effective as of April 30, 2025SELARSDI is approved for all indications matching the reference productSELARSDI is indicated for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis in adults and pediatric patients 6 years and older, and the treatment of adult patients with moderately to seve

GlobeNewswire 56 minutes ago

TEVA

TEVJF

ALVO
Greg Abel’s Challenge: Lead Berkshire Into a New Era Without the Buffett Touch

Warren Buffett has done what he can to prepare his successor at Berkshire Hathaway. But there is one thing that can’t be simply handed off: the Buffett brand.

The Wall Street Journal 1 hour ago

BRK-B
Netflix, Media Stocks Drop After Trump Orders Tariffs on Foreign-Made Films

U.S. President Donald Trump on Sunday said he has authorized a 100% tariff on movies made overseas. The news hit some media companies' shares in Monday-morning trading.

Investopedia 1 hour ago

NFLX

DIS
Warren Buffett to Remain Berkshire Hathaway Chairman

Buffett shocked the investing world Saturday when he said at Berkshire’s annual meeting that he planned to retire as chief executive at the end of the year and cede the role to Greg Abel. Buffett had said years earlier that Abel was on deck to succeed him, but many observers had thought the acclaimed stockpicker would remain CEO until his death. Buffett had previously said his son Howard would one day succeed him as Berkshire’s chairman, but the surprising decision to turn the CEO role to Abel at the end of year led some onlookers to question whether the timeline for Howard Buffett’s ascension had accelerated.

The Wall Street Journal 1 hour ago

BRK-B
5 Things to Know Before the Stock Market Opens Monday

News of the day for May 5, 2025

Investopedia 1 hour ago

^GSPC

DIS

PLTR
Warren Buffett delivered more than a 5,000,000% return to investors. This guy is going to replace him

Those who have followed Berkshire Hathaway have long-anticipated that the day would come when legendary investor and CEO Warren Buffett called it quits.

CNN Business 1 hour ago

BRK-B
TG Therapeutics: Q1 Earnings Snapshot

MORRISVILLE, N.Y. (AP) — TG Therapeutics Inc. TGTX) on Monday reported first-quarter earnings of $5.1 million. The Morrisville, New York-based company said it had net income of 3 cents per share.

Associated Press Finance 1 hour ago

TGTX
Berkshire Hathaway Q1 Earnings Decrease Y/Y on Higher Expenses

BRK.B's first-quarter results reflect lower earnings in insurance-underwriting, manufacturing, service and retailing businesses and other and escalating expenses.

Zacks 1 hour ago

BRK-B

CINF
Disney's Q2 Earnings Coming Up: Time to Buy, Sell or Hold the Stock?

DIS faces headwinds, including $150 million Sports impact, cruise expenses and subscriber declines. Consider reducing positions before fiscal Q2 earnings results.

Zacks 1 hour ago

DIS
BioCryst Reports First Quarter 2025 Financial Results and Provides Business Update

—Q1 2025 ORLADEYO net revenue of $134.2 million (+51 percent y-o-y)— —Full year 2025 ORLADEYO revenue guidance increased to $580 million to $600 million— —Company now expects to be profitable for full year 2025, a year ahead of schedule— —Company pays down $75 million of debt; saves approximately $23.5 million over life of loan— —NDA submitted for ORLADEYO oral granules for children with HAE aged 2-11— —U.S. IND open for BCX17725 for Netherton syndrome— RESEARCH TRIANGLE PARK, N.C., May 05, 2025

GlobeNewswire 1 hour ago

BCRX
Pershing Square to Invest $900 million to Acquire Nine Million Newly Issued Shares of Howard Hughes Holdings and Transform HHH Into a Diversified Holding Company

Pershing Square to Support HHH’s Strategic Expansion Through Investment, Advisory, and Other Resources HHH Will Operate as a Diversified Holding Company Seeking to Acquire Controlling Interests in High-Quality, Durable Growth Public and Private Companies Howard Hughes Corporation, HHH’s Real Estate Development Business and Principal Subsidiary, Will Continue as the Nation’s Leading Community Builder Pershing Square’s Primary Purchase of HHH Stock for $100.00 per Share Represents a 48% Premium to

GlobeNewswire 1 hour ago

HHH
TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance

First quarter 2025 BRIUMVI U.S. net revenue of $119.7 million Raises full year 2025 global net revenue target to approximately $575 million and raises full year BRIUMVI U.S. net revenue target to approximately $560 million Conference call to be held today, Monday, May 5, 2025, at 8:30 AM ET NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) (the Company or TG Therapeutics) today announced its financial results for the first quarter of 2025, along with recent company

GlobeNewswire 1 hour ago

TGTX
These Stocks Are Moving the Most Today: Berkshire Hathaway, Microsoft, Apple, Netflix, Palantir, and More

Berkshire Hathaway’s Class B shares fall after Warren Buffett says he’ll be stepping down as CEO at the end of the year, Microsoft kicks off Monday as the largest U.S. company by market cap, Netflix falls as President Donald Trump says he authorized a 100% tariff on films produced overseas. Palantir Technologies, meanwhile, is scheduled to report quarterly earnings Monday.

Barrons.com 1 hour ago

PLTR

AAPL

MSFT

Performance Overview

Return	000596.SZ	SSE Composite Index (000001.SS)
YTD	-4.58%	-2.17%
1-Year	-37.83%	+5.61%
3-Year	-11.81%	+7.61%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Anhui Gujing Distillery Co., Ltd. (000596.SZ)

Related News

Stock market today: Dow, S&P 500, Nasdaq futures slide as tariff fears revive to kick off big Fed week

Warren Buffett is stepping aside at Berkshire Hathaway. Here's what he thinks happens next.

Berkshire Hathaway (BRK.B) Sits on $300B Cash Pile, Plays the Long Game in Japan

Berkshire Hathaway (BRK.A) Surges as Buffett Prepares Exit After 60 Years

ON Semiconductor Corp.: Q1 Earnings Snapshot

onsemi Reports First Quarter 2025 Results

Ackman’s Pershing Square to Boost Stake in Howard Hughes Holdings

Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)

Greg Abel’s Challenge: Lead Berkshire Into a New Era Without the Buffett Touch

Netflix, Media Stocks Drop After Trump Orders Tariffs on Foreign-Made Films

Warren Buffett to Remain Berkshire Hathaway Chairman

5 Things to Know Before the Stock Market Opens Monday

Warren Buffett delivered more than a 5,000,000% return to investors. This guy is going to replace him

TG Therapeutics: Q1 Earnings Snapshot

Berkshire Hathaway Q1 Earnings Decrease Y/Y on Higher Expenses

Disney's Q2 Earnings Coming Up: Time to Buy, Sell or Hold the Stock?

BioCryst Reports First Quarter 2025 Financial Results and Provides Business Update

Pershing Square to Invest $900 million to Acquire Nine Million Newly Issued Shares of Howard Hughes Holdings and Transform HHH Into a Diversified Holding Company

TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance

These Stocks Are Moving the Most Today: Berkshire Hathaway, Microsoft, Apple, Netflix, Palantir, and More

Performance Overview